Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Essential Hypertension × candesartan × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 2 Multiple Endocrine Neoplasia Type 1 1 Heart Failure 1 Essential Hypertension 1 Cardiotoxicity 1 Barrett Esophagus 1

Interventions

candesartan 1 aliskiren 1 Exercise 1 Enalapril 1 Diuretics 1 Calcium Channel Blockers 1 Adrenergic beta-Antagonists 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01629225 2014-11-18

GRK4 Polymorphisms Blood Pressure Response to Candesartan

Third Military Medical University

Phase 4 Unknown

Essential Hypertension, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡